119-S-1320 DC Insider Whip Count Analysis

Breakdown — where votes are today

Status and visible support, by chamber and faction.

• Senate landscape: Republicans hold the majority (53–47 incl. I’s with Democrats); John Thune is Majority Leader. The bill was reported out of Senate Veterans’ Affairs on December 2, 2025, by Chairman Jerry Moran, with amendments and no written report. This signals bipartisan, non-controversial treatment in committee. [1]U.S. Senate — U.S. Senate: Party Division[2]Office of Sen. John Thune — Thune Delivers First Remarks as Senate Majority Lea…[3]Congress.gov — All Information for S.1320 (119th Congress)
• Sponsors/cosponsors: Lead sponsor Patty Murray (D-WA) with original GOP co-lead Joni Ernst (R-IA). Additional cosponsors span both parties, including Chair Moran; nine total as of December 1–2. Cross‑party sponsorship lowers conference/leadership friction. [4]Congress.gov — Cosponsors — S.1320 (119th)
• Visible VSO/advocacy posture: The American Legion has publicly endorsed the Servicewomen and Veterans Menopause Research Act; women’s‑health policy trackers list the Senate/House pair as active. These cues make suspension/UC packages easier to clear. [5]The American Legion — Advocating for women veterans on Capitol Hill[6]Society for Women’s Health Research — Legislative Tracker — SWHR
• House landscape: Republicans control the chamber; Mike Johnson remains Speaker despite visible internal strains, which can slow floor scheduling. The House companion (H.R. 2717 — Houlahan/Bice) sits in Armed Services and Veterans’ Affairs. Under typical practice, the House often takes up the Senate‑passed version on suspension. [7]The Guardian — Mike Johnson secures US House speakership after facing internal…[8]Congress.gov — All Information for H.R. 2717 (119th Congress)
• Committee gatekeepers: Senate VA is chaired by Moran (R-KS) with Blumenthal (D-CT) as RM; House VA is chaired by Bost (R-IL) with Takano (D-CA) as RM. Armed Services jurisdiction on the House side means Mike Rogers (R-AL) also has a say. All four have histories of moving bipartisan veterans’ items. [9]U.S. Senate — Committee on Veterans’ Affairs — Membership (Senate.gov)[10]Wikipedia — United States House Committee on Veterans' Affairs (119th)[11]House Armed Services Committee — Committee Chairmen | House Armed Services Comm…
• Policy scope: A directive to evaluate and plan research at VA/DoD on menopause and mid‑life women’s health; no new mandatory spending or contentious policy rider in the reported text — a profile that typically moves by UC/suspension. [12]Web search · turn 6 #3

Key legislators and likely swing points

Who can accelerate or stall the bill — and why.

• Sen. Jerry Moran (R-KS), SVAC Chair — pivotal to floor clearance. He reported the bill and is a listed cosponsor; his office can request hotline/UC or fold into a year‑end SVAC package. [3]Congress.gov — All Information for S.1320 (119th Congress)[4]Congress.gov — Cosponsors — S.1320 (119th)
• Sen. Patty Murray (D-WA) and Sen. Joni Ernst (R-IA), lead sponsors — bipartisan pairing with committee tenure; Murray has publicly pressed VA on resources at the May 21 hearing, keeping attention high. [13]Office of Sen. Patty Murray — Murray presses VA witness at May 21, 2025 hearing…
• Senate leadership — Majority Leader John Thune controls scarce December floor time; his conference has pledged to preserve the filibuster, making UC packages the fastest path for noncontroversial items. [2]Office of Sen. John Thune — Thune Delivers First Remarks as Senate Majority Lea…
• Potential UC hold risk — Sen. Rand Paul (R-KY) has a pattern of objecting to quick passage on cost/offset grounds and has recently leveraged objections during funding debates. No public indication he opposes S.1320, but he’s on the watch list for hotlined bills. [14]CBS News — Rand Paul blocks vote on 9/11 responders bill[15]Politico — Hemp rule creates turbulence for Senate vote to end shutdown
• House Speaker Mike Johnson (R-LA) — floor control. Despite intra‑GOP turmoil, veterans’ items commonly ride suspension with broad bipartisan votes; Johnson’s bandwidth and priorities still affect timing. [16]Washington Post — Stefanik spars with GOP House speaker as she seeks GOP nod fo…
• House VA Chair Mike Bost (R-IL) — likely to back veterans’ health research; recognized by VSOs this year, which typically correlates with moving consensus VA items. [17]Web search · turn 3 #2
• House Armed Services Chair Mike Rogers (R-AL) — HASC referral means his clearance matters if the House moves its own bill; more commonly, the House will take a Senate‑passed text on suspension to conserve floor time. [11]House Armed Services Committee — Committee Chairmen | House Armed Services Comm…

Leadership influence and procedural dynamics

How this moves — and where it can snag.

• Senate path of least resistance: Hotline then unanimous consent on the calendar, or inclusion in an end‑of‑year UC stack alongside other SVAC bills. One member can stall a UC package via a “hold,” which leadership often honors to avoid burning floor time on cloture. [18]Senate RPC — Senate Republican Policy Committee Glossary (Hold/Hotline)[19]Congressional Research Service — CRS: “Holds” in the Senate (R43563)
• If a hold materializes: Leaders can negotiate changes, set up a time agreement, or defer to the NDAA/omnibus track. Murray has already flagged NDAA as a potential vehicle, which would sidestep a standalone floor queue. [20]Office of Sen. Patty Murray — Murray/Houlahan introduce NDAA‑targeted menopause…
• House procedure: Most VA consensus items move under suspension of the rules (two‑thirds threshold, limited debate, no amendments). Given H.R. 2717’s dual referral, the cleaner path is to receive a Senate‑passed S.1320 and suspend to agree — avoiding dual‑committee markups. [8]Congress.gov — All Information for H.R. 2717 (119th Congress)
• Calendar pressure: Early December floor time is dominated by NDAA and year‑end appropriations clean‑up; Speaker Johnson’s internal rifts add unpredictability on scheduling even for noncontroversial bills. That argues for the Senate‑first, one‑vehicle strategy. [16]Washington Post — Stefanik spars with GOP House speaker as she seeks GOP nod fo…

Interest-group signals

Public positions that shape member comfort and floor time.

• American Legion explicitly supports the Servicewomen and Veterans Menopause Research Act — a strong green‑light for veterans’ committees and suspension/UC managers. [5]The American Legion — Advocating for women veterans on Capitol Hill
• DAV’s Women Veterans study links menopause to elevated depression/suicide risk — reinforcing the policy case many members cite when backing low‑cost research directives. [21]Disabled American Veterans — DAV Women Veterans Study — The Journey to Mental W…
• DoD/Defense Health Agency is actively convening menopause guideline focus groups — suggesting departmental receptivity that reduces executive‑branch friction. [22]Defense Health Agency — Defense Health Agency: Menopause patient focus groups (…

Assessment — whip count and odds

Bottom line for passage and timing.

• Senate vote math: With nine bipartisan cosponsors including the committee chair and no visible organized opposition, the cleanest path is UC. If forced to roll‑call, support should comfortably clear 60. Likelihood of Senate passage in the first session (by late December): moderate‑to‑high, contingent on avoiding a late UC hold. [4]Congress.gov — Cosponsors — S.1320 (119th)
• House prospects: High under suspension once a Senate vehicle arrives; Johnson’s floor capacity is the variable, but veterans’ consensus bills typically get time. [7]The Guardian — Mike Johnson secures US House speakership after facing internal…
• Most probable path: Senate UC or inclusion in an end‑of‑year SVAC/VA package; if crowded out, attach to NDAA or move early in the second session on a non‑controversial calendar. [20]Office of Sen. Patty Murray — Murray/Houlahan introduce NDAA‑targeted menopause…

Overall likelihood this Congress (enactment by end of 2026)

High (≈70–85%) — bipartisan sponsors, supportive committees, and VSO backing outweigh calendar/hold risks.

Near‑term (Dec 2025) Senate passage

Moderate to High — watch the hotline; single‑member objections could defer to January.

Confidence

Moderate — leadership and calendar dynamics are fluid in December, but institutional signals are favorable.